Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(2.03)
# 2,833
Out of 4,837 analysts
466
Total ratings
35.77%
Success rate
-7.83%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals | Assumes: Buy | $73 | $45.31 | +61.13% | 1 | May 19, 2025 | |
| CELC Celcuity | Reiterates: Buy | $27 | $10.67 | +153.05% | 7 | May 19, 2025 | |
| QSI Quantum-Si incorporated | Reiterates: Buy | n/a | $1.68 | - | 7 | May 19, 2025 | |
| PYXS Pyxis Oncology | Reiterates: Buy | $5 | $1.21 | +313.22% | 9 | May 19, 2025 | |
| RNXT RenovoRx | Reiterates: Buy | $3 | $1.22 | +145.90% | 3 | May 19, 2025 | |
| HUMA Humacyte | Assumes: Buy | $4 | $2.49 | +60.64% | 1 | May 14, 2025 | |
| ITOS iTeos Therapeutics | Downgrades: Neutral | n/a | $8.35 | - | 12 | May 14, 2025 | |
| DNTH Dianthus Therapeutics | Reiterates: Buy | $40 | $19.02 | +110.30% | 6 | May 13, 2025 | |
| OCGN Ocugen | Maintains: Buy | $8 → $7 | $0.81 | +764.20% | 21 | May 12, 2025 | |
| VOR Vor Biopharma | Downgrades: Neutral | n/a | $0.18 | - | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.43 | +366.42% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $9 | $4.96 | +81.45% | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $76.22 | +90.24% | 22 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $4 | $0.29 | +1,276.46% | 15 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.5 → $7 | $2.71 | +158.30% | 16 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 → $11 | $2.14 | +414.02% | 16 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.49 | +920.20% | 11 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.75 | +700.00% | 12 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.36 | +157.35% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.91 | +894.76% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.38 | - | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $1 | $0.33 | +204.79% | 9 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $20.87 | +19.79% | 18 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.41 | +325.53% | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.79 | +150.90% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $19.58 | +68.54% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $10.58 | +89.13% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $0.13 | +4,515.38% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $5.31 | +370.81% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.26 | +931.75% | 7 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $17.97 | +33.56% | 12 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $25.40 | +175.59% | 12 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $75.96 | +44.81% | 3 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $43.57 | +37.71% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $8.51 | +287.78% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.98 | +455.56% | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.41 | +1,105.40% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.10 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.17 | +53.42% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.87 | +969.52% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.95 | +205.08% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.49 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.45 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.21 | +643.80% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $2.33 | +972.96% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.56 | +220.51% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.26 | +1,415.15% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $1.89 | +534.92% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.39 | +5,007.25% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $17.07 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $80 | $1.75 | +4,484.53% | 5 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $3.68 | +63.04% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $7.68 | +95.31% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $8.03 | +310.96% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $12.97 | -26.75% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.90 | +736,742.11% | 1 | Mar 5, 2020 |
Mirum Pharmaceuticals
May 19, 2025
Assumes: Buy
Price Target: $73
Current: $45.31
Upside: +61.13%
Celcuity
May 19, 2025
Reiterates: Buy
Price Target: $27
Current: $10.67
Upside: +153.05%
Quantum-Si incorporated
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.68
Upside: -
Pyxis Oncology
May 19, 2025
Reiterates: Buy
Price Target: $5
Current: $1.21
Upside: +313.22%
RenovoRx
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $1.22
Upside: +145.90%
Humacyte
May 14, 2025
Assumes: Buy
Price Target: $4
Current: $2.49
Upside: +60.64%
iTeos Therapeutics
May 14, 2025
Downgrades: Neutral
Price Target: n/a
Current: $8.35
Upside: -
Dianthus Therapeutics
May 13, 2025
Reiterates: Buy
Price Target: $40
Current: $19.02
Upside: +110.30%
Ocugen
May 12, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $0.81
Upside: +764.20%
Vor Biopharma
May 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.18
Upside: -
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.43
Upside: +366.42%
May 7, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $4.96
Upside: +81.45%
May 6, 2025
Maintains: Buy
Price Target: $150 → $145
Current: $76.22
Upside: +90.24%
May 6, 2025
Maintains: Buy
Price Target: $9 → $4
Current: $0.29
Upside: +1,276.46%
May 2, 2025
Maintains: Buy
Price Target: $1.5 → $7
Current: $2.71
Upside: +158.30%
Apr 24, 2025
Reiterates: Buy
Price Target: $12 → $11
Current: $2.14
Upside: +414.02%
Apr 11, 2025
Reiterates: Buy
Price Target: $5
Current: $0.49
Upside: +920.20%
Apr 2, 2025
Reiterates: Buy
Price Target: $14
Current: $1.75
Upside: +700.00%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.36
Upside: +157.35%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.91
Upside: +894.76%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.38
Upside: -
Mar 21, 2025
Maintains: Buy
Price Target: $6 → $1
Current: $0.33
Upside: +204.79%
Mar 20, 2025
Reiterates: Buy
Price Target: $25
Current: $20.87
Upside: +19.79%
Mar 20, 2025
Reiterates: Buy
Price Target: $6
Current: $1.41
Upside: +325.53%
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $2.79
Upside: +150.90%
Mar 19, 2025
Reiterates: Buy
Price Target: $33
Current: $19.58
Upside: +68.54%
Mar 17, 2025
Initiates: Buy
Price Target: $20
Current: $10.58
Upside: +89.13%
Mar 14, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $0.13
Upside: +4,515.38%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $5.31
Upside: +370.81%
Mar 11, 2025
Reiterates: Buy
Price Target: $13
Current: $1.26
Upside: +931.75%
Mar 7, 2025
Maintains: Buy
Price Target: $22 → $24
Current: $17.97
Upside: +33.56%
Mar 3, 2025
Reiterates: Buy
Price Target: $70
Current: $25.40
Upside: +175.59%
Mar 3, 2025
Reiterates: Buy
Price Target: $110
Current: $75.96
Upside: +44.81%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $43.57
Upside: +37.71%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $8.51
Upside: +287.78%
Nov 29, 2024
Reiterates: Buy
Price Target: $11
Current: $1.98
Upside: +455.56%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.41
Upside: +1,105.40%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.10
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $7.17
Upside: +53.42%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $1.87
Upside: +969.52%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $2.95
Upside: +205.08%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.49
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.45
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.21
Upside: +643.80%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $2.33
Upside: +972.96%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.56
Upside: +220.51%
Nov 4, 2022
Maintains: Buy
Price Target: $3 → $4
Current: $0.26
Upside: +1,415.15%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $1.89
Upside: +534.92%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.39
Upside: +5,007.25%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $17.07
Upside: -
Feb 17, 2022
Maintains: Buy
Price Target: $150 → $80
Current: $1.75
Upside: +4,484.53%
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $3.68
Upside: +63.04%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $7.68
Upside: +95.31%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $8.03
Upside: +310.96%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $12.97
Upside: -26.75%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.90
Upside: +736,742.11%